A generic medicine is a medicine marketed under the name of its active ingredient rather than under the original manufacturer's distinctive brand name, or a medicinal product authorised as a generic equivalent of an established reference product. In ordinary UK usage, the generic name identifies the active substance, whereas the brand name is a name chosen by a pharmaceutical company for a particular marketed product.
NHS guidance gives sildenafil as an example of a generic medicine name and Viagra as an example of a brand name used for sildenafil. Generic medicines are not simply inferior copies or unregulated alternatives; authorised generic products must satisfy regulatory requirements for quality, safety and efficacy before they can be supplied.
The development of a generic medicine is closely connected with patents and market exclusivity. A new medicine is normally developed and initially marketed by a company that has obtained intellectual-property protection and regulatory authorisation. When relevant exclusivity periods expire, other manufacturers can seek authorisation to market medicines containing the same active substance. NHS information explains that once a patent expires, other manufacturers can market generic versions and that these versions contain the same active ingredients as the branded medicine. Generic competition can therefore allow multiple manufacturers to supply the same active substance and can substantially reduce medicine costs.
A generic medicine and its branded counterpart are expected to provide the same therapeutic effect when they are appropriately authorised and used in equivalent doses and indications. The active pharmaceutical ingredient is the principal component responsible for the intended pharmacological action, although the formulation can contain different inactive ingredients known as excipients. Excipients may include colouring agents, preservatives, fillers, binders, coatings, sweeteners or substances that affect the physical characteristics of a tablet or liquid.
Consequently, two authorised medicines containing the same active ingredient can look, taste or behave somewhat differently in terms of formulation without being therapeutically different in the intended pharmacological effect. This distinction explains why some people may notice differences in appearance or tolerability after a manufacturer change even though the active ingredient remains the same.
Generic medicines should not be confused with counterfeit, unauthorised or substandard medicines. A legitimate generic medicine has undergone the applicable regulatory assessment and is manufactured according to required quality standards. A counterfeit medicine, by contrast, falsely represents its identity, source or composition and may contain the wrong ingredient, incorrect amount, contaminants or no active ingredient. The MHRA warns that medicines obtained from unregistered online sources can potentially be fake, diluted, out of date or otherwise unsuitable. The fact that a medicine is inexpensive or sold under an unfamiliar generic name does not make it counterfeit; authorised generic medicines are an established part of modern pharmaceutical supply.
The term generic can have slightly different meanings depending on context. In everyday patient communication it often means a medicine prescribed or supplied using the active ingredient's non-proprietary name instead of a manufacturer's brand name. In pharmaceutical regulation, a generic medicinal product is a defined regulatory category associated with an existing reference medicine and must meet specified requirements. In pharmacology, generic name can also simply mean the established non-proprietary name of an active substance, regardless of whether the particular product is being discussed as a regulatory generic. These meanings overlap but are not identical, so statements such as "generic name" and "generic medicine" should not automatically be treated as interchangeable.
Generic prescribing can simplify identification of the active substance and facilitates competition between manufacturers. The NHS uses generic medicines extensively because they can provide equivalent therapeutic effects at considerably lower cost than branded versions in appropriate circumstances. Lower prices do not necessarily reflect lower manufacturing quality; they commonly reflect the fact that the generic manufacturer does not have to repeat the entire process of discovering and initially developing the original active substance and may not have the same brand-development expenses. Competition between suppliers can also reduce procurement costs and make medicines more economically sustainable for healthcare systems.
There are circumstances in which switching between manufacturers or formulations may require additional care. Some medicines have a narrow therapeutic index, meaning relatively small changes in drug exposure can have clinically important consequences, and some dosage forms have specialised release characteristics. Patient-specific factors, excipients, swallowing difficulties, allergies and formulation differences can also matter. Whether a particular medicine should routinely be substituted therefore depends on its regulatory and clinical characteristics rather than on the generic label alone. A pharmacist or prescriber can determine whether a specific product or manufacturer should be maintained when there is a clinically relevant reason to do so.
Generic medicines are an important part of evidence-based pharmaceutical practice because they separate the concept of a medicine's therapeutic substance from its commercial branding. A generic medicine may have a different colour, shape, packaging, manufacturer or tablet appearance while containing the same active substance and being authorised for the same relevant uses. The patient's attention should therefore be directed primarily to the active ingredient, strength, dosage form and instructions rather than assuming that a change in packaging necessarily means a change in treatment. UK medicine information and patient leaflets provide the authorised product information needed to identify active substances and understand how a specific product should be used.
